View:
United States securities and exchange commission logo
February 26, 2021
Barbara Guiterrez
Chief Financial Officer
InnovAge Holding Corp.
8950 E. Lowry Boulevard
Denver, Colorado 80230
Re: InnovAge Holding
Corp.
Amendment No. 2 to
Registration
Statement on Form S-1
Filed February 24,
2021
File No. 333-252853
Dear Ms. Guiterrez:
We have reviewed your amended registration statement and have
the following
comments. Please respond to this letter by amending your registration
statement and providing
the requested information. If you do not believe our comments apply to
your facts and
circumstances or do not believe an amendment is appropriate, please tell
us why in your
response.
After reviewing any amendment to your registration statement and
the information you
provide in response to these comments, we may have additional comments.
Amendment No. 2 to Registration Statement on Form S-1
Cover Page
1. Please remove the
reference to Apax Partners and Welsh, Carson, Anderson and Stowe as
"Sponsors" both on the
cover page and throughout the prospectus, as it does not appear
that either party has
any duties, obligations or roles beyond that of a controlling
shareholder.
Alternatively, revise the cover page and the Summary to clarify the meaning
that you ascribe to the
term. This explanation should address the "Sponsors" duties and
obligations, including,
with reference to the risk factor disclosure on page 55, that these
entities and their
affiliates may engage in activities where their interests conflict with the
company's interests or
those of its other shareholders, such as investing in or advising
businesses that
directly or indirectly compete with certain portions of the company's
business or are
suppliers or customers of the company.
Barbara Guiterrez
FirstName LastNameBarbara Guiterrez
InnovAge Holding Corp.
Comapany26,
February NameInnovAge
2021 Holding Corp.
February
Page 2 26, 2021 Page 2
FirstName LastName
Exhibits
2. As drafted the legal opinion states that the 16,666,667 shares covered
by the opinion
includes the 2,500,000 overallotment shares. However, the registration
statement seeks to
register a total of 19,166,667 shares, the 16,666,667 shares plus an
additional 2,500,000
shares for the overallotment. Please revise the legal opinion to
clearly cover the total
number of shares registered.
You may contact Michael Fay at (202) 551-3812 or Kate Tillan at (202)
551-3604 if you
have questions regarding the financial statements and related matters. Please
contact Abby
Adams at (202) 551-6902 or Laura Crotty at (202) 551-7614 with any other
questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Robert M. Hayward, P.C.